This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parr, T R
Right arrow Articles by Bryan, L E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parr, T R, Jr
Right arrow Articles by Bryan, L E

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1984 June; 25(6): 747-753

Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics.

T R Parr Jr and L E Bryan

ABSTRACT

The mechanism of non-beta-lactamase-mediated beta-lactam resistance in a clinical isolate of Haemophilus influenzae type b was studied. This clinical isolate showed up to a 32-fold increase in MICs of a wide variety of beta-lactams, including moxalactam and cefotaxime, although no beta-lactamase activity was detected, even after attempted induction. Transformation of broad-spectrum beta-lactam resistance into ampicillin-susceptible H. influenzae RDnov was accomplished. Examination of the outer membrane protein profile of the resistant parent by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of Triton X-100-extracted membranes revealed an unusual major outer membrane protein band at a molecular weight of 45,000. This outer membrane protein profile did not transform with beta-lactam resistance. Permeability differences were noted between the resistant strain and the nonisogenic susceptible strain of H. influenzae, although these penetration differences were not transformed. Comparison of the penicillin-binding protein profile of a resistant transformant with that of a susceptible parent with both whole-membrane preparations and whole-cell labeling, revealed a major reduction in binding affinity to penicillin-binding proteins 3a and 3b (molecular weights, 68,000 and 65,000, respectively). Thus, alteration in penicillin-binding proteins 3a and 3b correlated with the beta-lactam resistance.


Antimicrob Agents Chemother. 1984 June; 25(6): 747-753




This article has been cited by other articles:

  • Garcia-Cobos, S., Campos, J., Lazaro, E., Roman, F., Cercenado, E., Garcia-Rey, C., Perez-Vazquez, M., Oteo, J., de Abajo, F. (2007). Ampicillin-Resistant Non-{beta}-Lactamase-Producing Haemophilus influenzae in Spain: Recent Emergence of Clonal Isolates with Increased Resistance to Cefotaxime and Cefixime. Antimicrob. Agents Chemother. 51: 2564-2573 [Abstract] [Full Text]  
  • Tristram, S., Jacobs, M. R., Appelbaum, P. C. (2007). Antimicrobial Resistance in Haemophilus influenzae. Clin. Microbiol. Rev. 20: 368-389 [Abstract] [Full Text]  
  • Hasegawa, K., Kobayashi, R., Takada, E., Ono, A., Chiba, N., Morozumi, M., Iwata, S., Sunakawa, K., Ubukata, K., on behalf of the Working Group of the Nationwide S, (2006). High prevalence of type b {beta}-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced. J Antimicrob Chemother 57: 1077-1082 [Abstract] [Full Text]  
  • Hasegawa, K., Chiba, N., Kobayashi, R., Murayama, S. Y., Iwata, S., Sunakawa, K., Ubukata, K. (2004). Rapidly Increasing Prevalence of {beta}-Lactamase-Nonproducing, Ampicillin-Resistant Haemophilus influenzae Type b in Patients with Meningitis. Antimicrob. Agents Chemother. 48: 1509-1514 [Abstract] [Full Text]  
  • Kwon, D. H., Dore, M. P., Kim, J. J., Kato, M., Lee, M., Wu, J. Y., Graham, D. Y. (2003). High-Level {beta}-Lactam Resistance Associated with Acquired Multidrug Resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 47: 2169-2178 [Abstract] [Full Text]  
  • Straker, K., Wootton, M., Simm, A. M., Bennett, P. M., MacGowan, A. P., Walsh, T. R. (2003). Cefuroxime resistance in non-{beta}-lactamase Haemophilus influenzae is linked to mutations in ftsI. J Antimicrob Chemother 51: 523-530 [Abstract] [Full Text]  
  • Dabernat, H., Delmas, C., Seguy, M., Pelissier, R., Faucon, G., Bennamani, S., Pasquier, C. (2002). Diversity of {beta}-Lactam Resistance-Conferring Amino Acid Substitutions in Penicillin-Binding Protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother. 46: 2208-2218 [Abstract] [Full Text]  
  • Miyazaki, S., Fujikawa, T., Matsumoto, T., Tateda, K., Yamaguchi, K. (2001). Efficacy of azithromycin, clarithromycin and {beta}-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice. J Antimicrob Chemother 48: 425-430 [Abstract] [Full Text]  
  • Ubukata, K., Shibasaki, Y., Yamamoto, K., Chiba, N., Hasegawa, K., Takeuchi, Y., Sunakawa, K., Inoue, M., Konno, M. (2001). Association of Amino Acid Substitutions in Penicillin-Binding Protein 3 with {beta}-Lactam Resistance in {beta}-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 45: 1693-1699 [Abstract] [Full Text]  
  • Barry, A. L., Fuchs, P. C., Brown, S. D. (2001). Identification of {beta}-Lactamase-Negative, Ampicillin-Resistant Strains of Haemophilus influenzae with Four Methods and Eight Media. Antimicrob. Agents Chemother. 45: 1585-1588 [Abstract] [Full Text]  
  • DeLoney, C. R., Schiller, N. L. (2000). Characterization of an In Vitro-Selected Amoxicillin-Resistant Strain of Helicobacter pylori. Antimicrob. Agents Chemother. 44: 3368-3373 [Abstract] [Full Text]  
  • Seaton, R. A., Steinke, D. T., Phillips, G., MacDonald, T., Davey, P. G. (2000). Community antibiotic therapy, hospitalization and subsequent respiratory tract isolation of Haemophilus influenzae resistant to amoxycillin: a nested case-control study. J Antimicrob Chemother 46: 307-309 [Abstract] [Full Text]  
  • Hikida, M., Itahashi, K., Igarashi, A., Shiba, T., Kitamura, M. (1999). In Vitro Antibacterial Activity of LJC 11,036, an Active Metabolite of L-084, a New Oral Carbapenem Antibiotic with Potent Antipneumococcal Activity. Antimicrob. Agents Chemother. 43: 2010-2016 [Abstract] [Full Text]  
  • Joshi, M., Bernstein, J., Solomkin, J., Wester, B. A., Kuye, O. (1999). Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. J Antimicrob Chemother 43: 389-397 [Abstract] [Full Text]  
  • Gazagne, L., Delmas, C., Bingen, E., Dabernat, H. (1998). Molecular Epidemiology of Ampicillin-Resistant Non-beta -Lactamase-Producing Haemophilus influenzae. J. Clin. Microbiol. 36: 3629-3635 [Abstract] [Full Text]